Ortho-k for myopia control
- Ortho-k provides two benefits: correcting blurred vision from myopia, and slowing down myopia progression which is called myopia control.
- Ortho-k has the largest volume of evidence for myopia control in children and teenagers, compared to other treatments.
- How ortho-k provides a myopia control effect is believed to be due to the way it alters how peripheral light rays are brought to focus in front of the retina.
- If ortho-k is being used for myopia control and lens wear is stopped, it is important that eyes are carefully tracked to ensure that myopia remains stable, with ortho-k wear resumed if myopia is found to progress faster than expected.
In this article
When it comes to myopia control, there are more published peer reviewed papers on ortho-k than for any other method for slowing progression of myopia. Ortho-k has been shown to slow progression of myopia by around half compared to wearing standard glasses or contact lenses.
- What is myopia control?
- Ortho-k for myopia control
- How does ortho-k create a myopia control effect?
- Does ortho-k need to be modified for myopia control?
- Will myopia still progress with ortho-k?
- How long does ortho-k need to be worn for myopia control?
- Ortho-k and atropine eye drops
- Who should consider ortho-k for myopia control?
What is myopia control?
Myopia, also known as short-sightedness or near-sightedness, is not just about a pair of glasses. Once myopia (shortsightedness) in children and teenagers develops, it typically progresses or worsens every few months until the late teenage or early adulthood years.1
Myopia progression brings with it:
- Increasingly blurred vision
- The need for frequent changes in spectacle or contact lens prescription
- Increased risk of eye diseases and vision problems over a person’s lifetime.2
'Myopia control' has become the increasingly adopted term to describe any approach that aims to slow progression of myopia.
The good news it that there is now a huge body of evidence to support that myopia control can be achieved using specially designed glasses, contact lenses and ortho-k.
To learn more about myopia see our page What is myopia, and to learn more about myopia control read our article What is myopia control and why it's important.
Ortho-k for myopia control
Ortho-k is a special type of rigid contact lens which is worn overnight, while sleeping, to gently reshape the cornea (the clear dome at the front of the eye) so that daytime wear of glasses or contact lenses is not needed.3
Ortho-k is one of the first myopia vision correction options that has also been recognized to provide a myopia control effect, with current research indicating that ortho-k offers around a 50% myopia control effect.4,5 This means that ortho-k slows myopia progression by around a half compared to vision correction with standard single vision glasses or contact lenses.
Read more about how ortho-k works to correct vision, how they are fitted and what they are like to wear in What is ortho-k. To understand about safety of ortho-k read our article Are ortho-k lenses safe.
How does ortho-k create a myopia control effect?
How ortho-k provides a myopia control effect is not fully understood, but the most widely accepted reason is that it changes the way that light is focused inside the eye.
Ortho-k corrects myopia by gently flattening the cornea by a controlled amount. The cornea works like a lens, and through being flattened its focusing power is modified to bring light back into focus on the retina and correct vision.
To learn more about how ortho-k lenses correction vision see the section How ortho-k lenses work in our article What is ortho-k.
It just happens that the way the cornea is flattened by ortho-k also creates a unique shape profile, which causes some light rays to bend in different ways. The light rays that enter the cornea most closely to its center, called central light rays, are brought into focus at the center of the retina to provide clear vision. The light rays that enter towards the edge of the cornea are called peripheral light rays, and these are instead brought into focus in front of the retina.
Ortho-k focuses peripheral light rays to focus in front of the retina, which is believed to act as a stop signal to eye growth, which slows progression of myopia.
Studies have shown that myopia eye growth can be slowed when peripheral light rays are focused in front of the retina, which is exactly what ortho-k does when it is used to correct myopia.3 Researchers explain that bringing peripheral light rays into focus in front of the retina acts like a stop signal for eye growth.
To learn more about myopia control read our article What is myopia control and why it's important.
Does ortho-k need to be modified for myopia control?
There are many different contact lens manufacturers making ortho-k lenses, and consequently many different ortho-k lens designs in the market. The majority of published myopia control research into ortho-k has used these 'standard' types of ortho-k lens designs, which indicates that a myopia control effect can be expected from wearing a standard ortho-k lens design.
You've just learned that standard ortho-k lens designs provide a 50% myopia control effect. While this is still around the largest myopia control effect that can be expected right now,6 researchers are still keen to see if ortho-k's myopia control effect can be improved.
The approach that most researchers have taken is to modify ortho-k lens designs so that they either bend more peripheral light rays to focus in front of the retina, or increase how far in front of the retina the peripheral light rays are focused. The general premise is that this will create a stronger myopic eye growth stop signal and thereby a stronger myopia control effect.
Current research shows promising signs that ortho-k lenses can be modified to increase the myopia control effect, although these modified lenses can be slightly less easy to fit. More longer term studies are needed.7
Modified ortho-k lens designs show promise for providing an improved myopia control effect, but long term studies need to be undertaken. Until then, standard ortho-k lens designs are known to provide a 50% myopia control effect, which is among the highest effect that research shows can be expected right now.
Will myopia still progress with ortho-k?
The short answer is yes. Ortho-k provides a 50% myopia control effect, causing it to slow myopia progression by around half.4,5 This means it's normal for myopia to progress even while wearing ortho-k lenses for myopia control, and this should in fact be expected.
How much myopia will progress while wearing ortho-k lenses depends on many factors, particularly age, sex and ethnicity. Myopia typically progresses at a faster rate in younger years, which varies between boys and girls at different ages, and typically progresses faster in Asian compared to Caucasian children.1
At eye care visits, the optometrist or eye doctor is able to measure myopia and compare against average expected myopia progression rates to advise whether myopia is progressing as expected. However, you need to be aware that knowledge on human myopia progression is still growing, and there are currently no fully reliable measures for how much and how fast myopia will progress in an individual. This means that the eye doctor can only advise whether myopia is progressing within the expected range.
The International Myopia Institute recommends six monthly checkups when ortho-k is used for myopia control.8
Because ortho-k provides 50% myopia control it should not be expected to stop myopia progressing. However, any slowing of myopia progression will help reduce higher myopia in adulthood and therefore be beneficial in reducing the likelihood of sight threatening eye disease later in life.2,6
How long does ortho-k need to be worn for myopia control?
Most myopia progression typically occurs throughout childhood and comes to a stop in the late teens or early adulthood,1 though it can continue throughout the twenties. Ortho-k lenses can only control myopia progression while wear continues, which means that to be effective for myopia control, ortho-k wear should be continued throughout childhood.
There is limited research on what happens to myopia progression when ortho-k wear is stopped, but one study reported that children who stopped before age 14 experienced faster progression, or a 'rebound effect'. This was resolved as soon as ortho-k wear was recommenced.
Their advice was that myopia progression should be monitored closely if ortho-k for myopia control is stopped, and ortho-k wear resumed if myopia is found to progress faster than during ortho-k wear.9
If ortho-k is being used for myopia control and lens wear is stopped, it is important that eyes are carefully tracked to ensure that myopia remains stable, with ortho-k wear resumed if myopia is found to progress faster than expected.
Ortho-k and atropine eye drops
Research has shown that atropine eye drops can be used at night, before putting on ortho-k lenses, to increase the myopia control effect of ortho-k. The combined effect appears to happen only in the first six months,10 and more research is needed to understand for whom this could be most beneficial.
Read more about atropine eye drops for myopia control: see the section Why is atropine eye used for myopia control? in our article All about atropine.
Who should consider ortho-k for myopia control?
Because myopia typically progresses faster at younger ages,1 it would be beneficial to start any myopia control treatment at the earliest opportunity, and ideally from when myopia is first detected.6
However, when it comes to ortho-k, age limits are introduced because a child needs to be capable of handling ortho-k lenses and being comfortable with the measurements that need to be taken. How young will depend on the individual child but published studies have included children from age 6.3
Ortho-k is suitable for children from age 6, as long as the child is able to handle the lenses and is comfortable with the measurements that need to be taken.
There is strong evidence for ortho-k in myopia control for children aged 6-16 years,4,5 and a small amount of evidence that ortho-k can also stabilize myopia in older teens and young adults.11,12
For age specific content on ortho-k for myopia control see our following articles:
- Hou W, Norton TT, Hyman L, Gwiazda J; COMET Group. Axial Elongation in Myopic Children and its Association With Myopia Progression in the Correction of Myopia Evaluation Trial. Eye Contact Lens. 2018 Jul;44(4):248-259. (link)
- Tideman JW, Snabel MC, Tedja MS, van Rijn GA, Wong KT, Kuijpers RW, Vingerling JR, Hofman A, Buitendijk GH, Keunen JE, Boon CJ, Geerards AJ, Luyten GP, Verhoeven VJ, Klaver CC. Association of Axial Length With Risk of Uncorrectable Visual Impairment for Europeans With Myopia. JAMA Ophthalmol. 2016 Dec 1;134(12):1355-1363.
- Vincent SJ, Cho P, Chan KY, Fadel D, Ghorbani-Mojarrad N, González-Méijome JM, Johnson L, Kang P, Michaud L, Simard P, Jones L. CLEAR - Orthokeratology. Cont Lens Anterior Eye. 2021 Apr;44(2):240-269. (link)
- Sun Y, Xu F, Zhang T, Liu M, Wang D, Chen Y, Liu Q. Orthokeratology to control myopia progression: a meta-analysis. PLoS One. 2015 Apr 9;10(4):e0124535.
- Cho P, Cheung SW. Protective Role of Orthokeratology in Reducing Risk of Rapid Axial Elongation: A Reanalysis of Data From the ROMIO and TO-SEE Studies. Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1411-1416. (link)
- Brennan NA, Toubouti YM, Cheng X, Bullimore MA. Efficacy in myopia control. Prog Retin Eye Res. 2021 Jul;83:100923. (link)
- Guo B, Cheung SW, Kojima R, Cho P. One-year results of the Variation of Orthokeratology Lens Treatment Zone (VOLTZ) Study: a prospective randomised clinical trial. Ophthalmic Physiol Opt. 2021 Jul;41(4):702-714.
- Gifford KL, Richdale K, Kang P, Aller TA, Lam CS, Liu YM, Michaud L, Mulder J, Orr JB, Rose KA, Saunders KJ, Seidel D, Tideman JWL, Sankaridurg P. IMI - Clinical Management Guidelines Report. Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M184-M203.
- Cho P, Cheung SW. Discontinuation of orthokeratology on eyeball elongation (DOEE). Cont Lens Anterior Eye. 2017 Apr;40(2):82-87. (link)
- Tan Q, Ng AL, Cheng GP, Woo VC, Cho P. Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trial. Cont Lens Anterior Eye. 2022 May 30:101723. (link)
- Gifford KL, Gifford P, Hendicott PL, Schmid KL. Zone of Clear Single Binocular Vision in Myopic Orthokeratology. Eye Contact Lens. 2020 Mar;46(2):82-90. (link)
- González-Méijome JM, Carracedo G, Lopes-Ferreira D, Faria-Ribeiro MA, Peixoto-de-Matos SC, Queirós A. Stabilization in early adult-onset myopia with corneal refractive therapy. Cont Lens Anterior Eye. 2016 Feb;39(1):72-7. (link)